Main Navigation
 
Search
Advanced Search>>
Free Newsletter
Subscribe
Unsubscribe
 
 
  
Health Headlines

Get the latest news in prevention and health matters. This feature includes daily postings and recent archives to keep you up to date on health reports and wires around the world.
Weekly Wellness
Get informed with weekly wellness facts in a diversity of health topics from prevention to fitness and nutrition.
Tips
Great tips on what you need to know about keeping healthy and active all year round.

 
GlaxoSmithKline To Start Shipping
Untested H1N1 Vaccines Next Week

GlaxoSmithKline who have not completed any clinical trials to assess the safety of H1N1 vaccines, expects to start shipping out its vaccine next week to governments across Europe so that mass vaccinations against the virus can begin.

Governments and drugmakers have been scrambling for vaccines to combat the new H1N1 flu strain before a fear hyped second wave of infection hits the northern hemisphere in the winter.

The world's second biggest pharmaceutical company said on Wednesday it will begin shipments of its Pandemrix vaccine from next week, after getting official clearance from the European Commission on Tuesday.

According to infectious disease experts, due to delayed and potentially serious side effects, the timelines for effective safety testing on adjuvanted vaccines should span years from initial clinical trials. Yet the vaccines about to be shipped to Europeans offer no data or conclusive evidence to health regulators on vaccine safety.

A full list of ingredients, warnings and side effects for all H1N1 vaccine inserts is available here.

European officials also gave a green light to Swiss drugmaker Novartis for its H1N1 shot Focetria which also contains untested and dangerous adjuvants such as MF59.

Reference Sources 89
September 30, 2009

 
Select a Channel